Status:
COMPLETED
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Lead Sponsor:
Jeffrey L. Lacy
Collaborating Sponsors:
University of Wisconsin, Madison
Conditions:
Renal Failure
Renal Artery Stenosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Two investigational chemical tracers, 62Cu-ethylglyoxal bis(thiosemicarbazone) (62Cu-ETS) and 15O-water, will be used in this study to look at how blood moves through the kidneys. The purpose of the s...
Eligibility Criteria
Inclusion
- Arm 1.
- males and females, age 18-40 years
- willingness to provide written informed consent
Exclusion
- history of coronary artery disease (CAD)
- history of renal disease
- risk factors for cardiac disease, renal disease, or atherosclerosis, including diabetes mellitus, hypertension, tobacco abuse, hyperlipidemia, family history of CAD or chronic renal failure
- history of liver disease or other significant disease
- pregnant females
- Arm 2.
- Inclusion Criteria:
- males and females, age \> 18 years
- active hemodialysis or peritoneal dialysis for at least six months
- any etiology of chronic renal failure except active glomerular nephritis
- presence of two kidneys
- willingness to provide written informed consent
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00714142
Start Date
August 1 2008
End Date
April 1 2009
Last Update
April 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin - Madison
Madison, Wisconsin, United States, 53792